A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adolescent Subjects



Status:Active, not recruiting
Conditions:Constipation
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:12 - 17
Updated:4/21/2016
Start Date:December 2015

Use our guide to learn which trials are right for you!

The objective of this study is to evaluate the safety and efficacy of BLI400 laxative in
constipated adolescent subjects.


Inclusion Criteria:

- Male or female subjects at between 12-17 years of age

- Weight more than 40 kg (88 lbs.).

- Constipated, defined by the following criteria

1. Fewer than 3 spontaneous defecations per week and at least one of the following
symptoms for at least 12 weeks (which need not be consecutive) in the preceding
12 months:

1. Straining during > 25% of defecations

2. Lumpy or hard stools in > 25% of defecations

3. Sensation of incomplete evacuation for > 25% of defecations

2. Loose stools are rarely present without the use of laxatives

3. There are insufficient criteria for irritable bowel syndrome - loose (mushy) or
watery stool in the absence of laxative use for more than 25% of bowel movements

Criteria A, B and C must be fulfilled for the last 12 weeks with symptom onset at least 6
months prior to diagnosis.

- Otherwise in good health, as determined by physical exam and medical history

- If female, and of child-bearing potential, is using an acceptable form of birth
control (hormonal birth control, intrauterine device, double-barrier method, depot
contraceptive, sterilized, or abstinence)

- Negative urine pregnancy test at screening, if applicable

- In the Investigator's judgment, subject is mentally competent to provide informed
consent to participate in the study

Exclusion Criteria:

- Subjects with known or suspected ileus, gastrointestinal obstruction, gastric
retention, bowel perforation, toxic colitis, toxic megacolon

- Subjects who have had major surgery 30 days before Visit 1; appendectomy or
cholecystectomy 60 days before Visit 1; abdominal, pelvic, or retroperitoneal surgery
6 months before Visit 1; bariatric surgery or surgery to remove a segment of the GI
tract at any time before Visit 1

- Subjects with hypothyroidism that is being treated and for which the dose of thyroid
hormone has not been stable for at least 6 weeks at the time of Visit 1

- Subjects taking laxatives, enemas or prokinetic agents that refuse to discontinue
these treatments from Visit 1 until after completion of Visit 3

- Subjects who are pregnant or lactating, or intend to become pregnant during the study

- Subjects of childbearing potential who refuse a pregnancy test

- Subjects who are allergic to the study medication

- Subjects taking narcotic analgesics or other medications known to cause constipation

- Subjects who, in the opinion of the Investigator, should not be included in the study
for any reason, including inability to follow study procedures

- Subjects who have participated in an investigational clinical, surgical, drug, or
device study within the past 30 days

- Subjects with an active history of drug or alcohol abuse

- Subjects have been hospitalized for a psychiatric condition or have made a suicide
attempt during the 2 years before Visit 1

- Subjects who withdraw consent at any time prior to completion of Visit 1 procedures
We found this trial at
3
sites
Richland, Washington 99352
?
mi
from
Richland, WA
Click here to add this to my saved trials
Miami, Florida 33144
?
mi
from
Miami, FL
Click here to add this to my saved trials
Palmetto Bay, Florida 33157
?
mi
from
Palmetto Bay, FL
Click here to add this to my saved trials